Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biotage AB (BITGF)
OTHER OTC:BITGF
Biotage AB (BITGF) Stock Price & Analysis
8 Followers
BITGF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$7.69 - $18.22
Previous Close$15.62
Volume300.00
Average Volume (3M)248.00
Market Cap
$1.26B
Enterprise Value$1.24B
Total Cash (Recent Filing)kr441.00M
Total Debt (Recent Filing)kr217.00M
Price to Earnings (P/E)55.1
Beta0.78
Next Earnings
Jul 16, 2024EPS Estimate
$0.07Next Dividend Ex-DateN/A
Dividend Yield0.96%
Share Statistics
EPS (TTM)0.28
Shares Outstanding80,008,185
10 Day Avg. Volume30
30 Day Avg. Volume248
Standard Deviation0.14
R-Squared0.09
Alpha0.00795
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Biotage AB News
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
3.32% Mutual Funds
3.75% Other Institutional Investors
92.93% Public Companies and
Individual Investors
BITGF FAQ
What was Biotage AB’s price range in the past 12 months?
Biotage AB lowest stock price was $7.69 and its highest was $18.22 in the past 12 months.
What is Biotage AB’s market cap?
Currently, no data Available
When is Biotage AB’s upcoming earnings report date?
Biotage AB’s upcoming earnings report date is Jul 16, 2024 which is in 68 days.
How were Biotage AB’s earnings last quarter?
Biotage AB released its earnings results on Apr 25, 2024. The company reported $0.058 earnings per share for the quarter, beating the consensus estimate of $0.049 by $0.009.
Is Biotage AB overvalued?
According to Wall Street analysts Biotage AB’s price is currently Overvalued.
Does Biotage AB pay dividends?
Biotage AB does not currently pay dividends.
What is Biotage AB’s EPS estimate?
Biotage AB’s EPS estimate is $0.07.
How many shares outstanding does Biotage AB have?
Biotage AB has 80,008,190 shares outstanding.
What happened to Biotage AB’s price movement after its last earnings report?
Biotage AB reported an EPS of $0.058 in its last earnings report, beating expectations of $0.049. Following the earnings report the stock price went down -1.349%.
Which hedge fund is a major shareholder of Biotage AB?
Currently, no hedge funds are holding shares in BITGF
---
Biotage AB Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
8.62%
12-Months-Change
Fundamentals
Return on Equity
8.43%
Trailing 12-Months
Asset Growth
111.32%
Trailing 12-Months
Company Description
Biotage AB
Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. The company has divided its products into the areas of organic chemistry, analytical chemistry, and industrial products. Its product portfolio encompasses biotage extrahera, biotage pressure, gravity rack, cartridge processing stations etc. Its clients include government agencies, academic institutions and the pharmaceutical and food industries.
---
BITGF Company Deck
---
BITGF Earnings Call
Q1 2024
0:00 / 0:00
---
BITGF Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering BITGF
1 Year
1 Year Success Rate
4/8 ratings generated profit
1 Year Average Return
+5.71%
reiterated a buy rating 4 months ago
Copying Odysseas Manesiotis's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +5.71% per trade.
---